(BKSE) BNY Mellon Trust - BNY - Ratings and Ratios
Equity, Derivatives, Small-Cap, ETFs, Securities
Description: BKSE BNY Mellon Trust - BNY
The BNY Mellon US Small Cap Core Equity ETF (BKSE) is an exchange-traded fund that focuses on investing in the equity securities of small-capitalization U.S. companies, as well as ETFs and derivatives that provide similar exposure. Under normal market conditions, the fund allocates at least 80% of its net assets, plus any borrowings for investment purposes, to these small-cap U.S. equities. The underlying index it tracks is a free float market capitalization weighted index, designed to measure the performance of 600 small-cap companies listed on U.S. stock markets.
The funds investment strategy is centered around providing investors with exposure to the small-cap segment of the U.S. equity market, which is known for its potential for growth, albeit with higher volatility compared to larger capitalization stocks. By tracking a broad index of 600 small-cap companies, the fund aims to offer diversified exposure within this segment, despite being classified as non-diversified. This means that while it tracks a sizable number of stocks, it doesnt necessarily spread its investments across various asset classes or sectors outside of its core focus.
Analyzing the funds recent performance and technical indicators, we observe that it has shown a positive trend relative to its short-term moving averages (SMA20 and SMA50), indicating a potential upward momentum. However, its current price is below its long-term SMA200, suggesting that it might be in a correction phase or consolidating after a previous uptrend. The Average True Range (ATR) indicates a moderate level of volatility, which is expected given its focus on small-cap stocks.
Given the current technical and fundamental data, a forecast for BKSE could involve a potential rebound or consolidation phase. With the last price at $97.75 and SMA20 at $91.90, theres an indication of short-term bullishness. However, being below the SMA200 at $98.45 might indicate a longer-term bearish trend or a need for the fund to regain its upward momentum. The AUM of $89.12M USD suggests a relatively modest size, which could be both a positive and a negative - it allows for agility but might also limit its appeal to larger investors. If the overall market sentiment towards small-cap stocks improves, and given the funds low expense ratio (not explicitly mentioned but typically a characteristic of index ETFs), BKSE might be poised for growth, potentially challenging its 52-week high of $110.13. Conversely, a downturn could see it testing its 52-week low of $80.66. Thus, investors should closely monitor market conditions, the performance of the underlying index, and the overall economic outlook to make informed decisions.
BKSE ETF Overview
Market Cap in USD | 63m |
Category | Small Blend |
TER | 0.04% |
IPO / Inception | 2020-04-07 |
BKSE ETF Ratings
Growth Rating | 31.8 |
Fundamental | - |
Dividend Rating | 58.5 |
Rel. Strength | 1.26 |
Analysts | - |
Fair Price Momentum | 98.95 USD |
Fair Price DCF | - |
BKSE Dividends
Dividend Yield 12m | 1.37% |
Yield on Cost 5y | 2.21% |
Annual Growth 5y | 17.73% |
Payout Consistency | 100.0% |
Payout Ratio | % |
BKSE Growth Ratios
Growth Correlation 3m | 82.9% |
Growth Correlation 12m | -9.9% |
Growth Correlation 5y | 54% |
CAGR 5y | 10.67% |
CAGR/Max DD 5y | 0.37 |
Sharpe Ratio 12m | 0.05 |
Alpha | -7.05 |
Beta | 1.004 |
Volatility | 18.49% |
Current Volume | 0.9k |
Average Volume 20d | 1.4k |
Stop Loss | 102.1 (-3.1%) |
Signal | 2.06 |
What is the price of BKSE shares?
Over the past week, the price has changed by +4.37%, over one month by +2.49%, over three months by +9.37% and over the past year by +13.10%.
Is BNY Mellon Trust - BNY a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BKSE is around 98.95 USD . This means that BKSE is currently overvalued and has a potential downside of -6.05%.
Is BKSE a buy, sell or hold?
What are the forecasts/targets for the BKSE price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 111.5 | 5.9% |
Last update: 2025-08-06 04:32
BKSE Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.2
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 62.6m USD (62.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 62.6m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 62.6m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(62.6m)/V(0.0) * Re(9.71%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BKSE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle